Ketorolac Versus Ibuprofen to Treat Painful Episodes of Sickle Cell Disease

NCT00115336 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped Poor accrual

Conditions

Hematologic Diseases
Anemia, Sickle Cell

Interventions

DRUG: Intravenous Ketorolac
DRUG: Ibuprofen

Sponsor

Children's Hospital Medical Center, Cincinnati

Collaborators

[object Object]
[object Object]